OPC Pharmaceutical Joint Stock Company
OPC Pharmaceutical Joint Stock Company, commonly referred to as OPC Pharma, is a prominent player in the pharmaceutical industry, headquartered in Vietnam. Established in 1976, the company has made significant strides in the production and distribution of high-quality pharmaceutical products, primarily focusing on prescription medications and over-the-counter solutions. With a strong operational presence across various regions in Vietnam, OPC Pharma is renowned for its commitment to innovation and quality. The company offers a diverse range of core products, including generic drugs and herbal medicines, distinguished by their efficacy and safety. OPC Pharma's dedication to research and development has positioned it as a leader in the Vietnamese market, earning accolades for its contributions to healthcare and patient well-being.
DitchCarbon Score
How does OPC Pharmaceutical Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
OPC Pharmaceutical Joint Stock Company's score of 10 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
OPC Pharmaceutical Joint Stock Company's reported carbon emissions
OPC Pharmaceutical Joint Stock Company, headquartered in Vietnam, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that the company may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the pharmaceutical industry increasingly prioritises sustainability, OPC Pharmaceutical may benefit from establishing clear emissions reduction goals and commitments to align with global climate standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
OPC Pharmaceutical Joint Stock Company is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
